<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 14 Mar 2021 12:40:43 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>科伦、扬子江、正大天晴......46个新药获批临床！齐鲁拿下第2款口溶膜，GSK新药来袭</title><link>https://mp.weixin.qq.com/s/DLFFL4PKeYNTvSLKi6IxKw</link><description></description><content:encoded><![CDATA[科伦、扬子江、正大天晴......46个新药获批临床！齐鲁拿下第2款口溶膜，GSK新药来袭]]></content:encoded><pubDate>Sun, 14 Mar 2021 07:48:43 +0800</pubDate></item><item><title>60亿流感“神药”危险了，独家剂型遇劲敌！四川药企再发威，带量采购要联动？</title><link>https://mp.weixin.qq.com/s/-LnCYKrCCB5SDMEvcJ7tPQ</link><description></description><content:encoded><![CDATA[60亿流感“神药”危险了，独家剂型遇劲敌！四川药企再发威，带量采购要联动？]]></content:encoded><pubDate>Sat, 13 Mar 2021 08:01:16 +0800</pubDate></item><item><title>恒瑞、信立泰、华东……11款1类新药霸屏！285亿市场DPP-4降糖药崛起，科伦抢首仿</title><link>https://mp.weixin.qq.com/s/j8x-DOmVxti-fbQq0tD9cQ</link><description></description><content:encoded><![CDATA[恒瑞、信立泰、华东……11款1类新药霸屏！285亿市场DPP-4降糖药崛起，科伦抢首仿]]></content:encoded><pubDate>Fri, 12 Mar 2021 16:04:39 +0800</pubDate></item><item><title>【瞩目】厉害了！石药集团3大重磅品种过评</title><link>https://mp.weixin.qq.com/s/DmNbKiLYlwbrzIkyE8kFiQ</link><description></description><content:encoded><![CDATA[【瞩目】厉害了！石药集团3大重磅品种过评]]></content:encoded><pubDate>Fri, 12 Mar 2021 16:04:39 +0800</pubDate></item><item><title>【市场】80亿“神药”跌落神坛，江苏药企发力</title><link>https://mp.weixin.qq.com/s/GkIRFeo7eoz7uCj3KS0Fog</link><description></description><content:encoded><![CDATA[【市场】80亿“神药”跌落神坛，江苏药企发力]]></content:encoded><pubDate>Fri, 12 Mar 2021 16:04:39 +0800</pubDate></item><item><title>【审评】20亿抗抑郁药！这家药企将拿下</title><link>https://mp.weixin.qq.com/s/6a8UPKTaKbg-FhnuNHMS2Q</link><description></description><content:encoded><![CDATA[【审评】20亿抗抑郁药！这家药企将拿下]]></content:encoded><pubDate>Fri, 12 Mar 2021 16:04:39 +0800</pubDate></item><item><title>最燃药议！集采、目录调整、网售处方药、中医药……22位大佬说出你的心声了吗</title><link>https://mp.weixin.qq.com/s/7WW_b2U8iTcJ9kpehHgzGw</link><description></description><content:encoded><![CDATA[最燃药议！集采、目录调整、网售处方药、中医药……22位大佬说出你的心声了吗]]></content:encoded><pubDate>Thu, 11 Mar 2021 16:35:09 +0800</pubDate></item><item><title>【重磅】齐鲁新药获批，30亿大品种再添猛将！3大新药在路上</title><link>https://mp.weixin.qq.com/s/r16Uh0aElH5OBCGNlPloxA</link><description></description><content:encoded><![CDATA[【重磅】齐鲁新药获批，30亿大品种再添猛将！3大新药在路上]]></content:encoded><pubDate>Thu, 11 Mar 2021 16:35:09 +0800</pubDate></item><item><title>【热议】世界肾脏病日，关爱慢性肾病患者</title><link>https://mp.weixin.qq.com/s/5hofvYut0K7H8ALanfRKiQ</link><description></description><content:encoded><![CDATA[【热议】世界肾脏病日，关爱慢性肾病患者]]></content:encoded><pubDate>Thu, 11 Mar 2021 16:35:09 +0800</pubDate></item><item><title>​【火爆】四川药企拿下诺华超20亿心血管大品种，原研败退</title><link>https://mp.weixin.qq.com/s/Qo8uSm74o1VvpLcSf8RYrw</link><description></description><content:encoded><![CDATA[​【火爆】四川药企拿下诺华超20亿心血管大品种，原研败退]]></content:encoded><pubDate>Thu, 11 Mar 2021 16:35:09 +0800</pubDate></item><item><title>东阳光药放大招！3个重磅新品来袭，30款1类新药亮眼，冲刺600亿市场龙头宝座</title><link>https://mp.weixin.qq.com/s/n0h3yGGSKW7hcdnd6oMNAg</link><description></description><content:encoded><![CDATA[东阳光药放大招！3个重磅新品来袭，30款1类新药亮眼，冲刺600亿市场龙头宝座]]></content:encoded><pubDate>Wed, 10 Mar 2021 16:04:54 +0800</pubDate></item><item><title>【重磅】科伦抢首仿，瞄准超$40亿明星药</title><link>https://mp.weixin.qq.com/s/EQK2hT1_g-2KdzwkCKOk0w</link><description></description><content:encoded><![CDATA[【重磅】科伦抢首仿，瞄准超$40亿明星药]]></content:encoded><pubDate>Wed, 10 Mar 2021 16:04:54 +0800</pubDate></item><item><title>【数据】药店最畅销的5款痛风药曝光，榜首遭“围攻”</title><link>https://mp.weixin.qq.com/s/u7jo4VhnL2u5odz_uaR_vQ</link><description></description><content:encoded><![CDATA[【数据】药店最畅销的5款痛风药曝光，榜首遭“围攻”]]></content:encoded><pubDate>Wed, 10 Mar 2021 16:04:54 +0800</pubDate></item><item><title>【瞩目】国产1类新药获批，超百亿市场大突破</title><link>https://mp.weixin.qq.com/s/ursbr5UR9z0DOfqCQmSBOg</link><description></description><content:encoded><![CDATA[【瞩目】国产1类新药获批，超百亿市场大突破]]></content:encoded><pubDate>Wed, 10 Mar 2021 16:04:54 +0800</pubDate></item><item><title>这家四川药企厉害！3大爆款1类新药将陆续上市，8大重磅品种抢首仿、首家过评</title><link>https://mp.weixin.qq.com/s/vO-mZ2TM3xGg2xsssdUVyw</link><description></description><content:encoded><![CDATA[这家四川药企厉害！3大爆款1类新药将陆续上市，8大重磅品种抢首仿、首家过评]]></content:encoded><pubDate>Tue, 09 Mar 2021 16:26:55 +0800</pubDate></item><item><title>【瞩目】国产第3家！科伦将拿下$8亿大品种</title><link>https://mp.weixin.qq.com/s/73zuyZShbmhQVd2qZhZykQ</link><description></description><content:encoded><![CDATA[【瞩目】国产第3家！科伦将拿下$8亿大品种]]></content:encoded><pubDate>Tue, 09 Mar 2021 16:26:55 +0800</pubDate></item><item><title>【重磅】正大天晴将拿下仑伐替尼首仿</title><link>https://mp.weixin.qq.com/s/F6VUqMfsWxIK22Jp7uRwXQ</link><description></description><content:encoded><![CDATA[【重磅】正大天晴将拿下仑伐替尼首仿]]></content:encoded><pubDate>Tue, 09 Mar 2021 16:26:55 +0800</pubDate></item><item><title>【市场】80亿降压药白云山过评，39家药企激战</title><link>https://mp.weixin.qq.com/s/AUmzBdZUvhCxX8MHfXW27A</link><description></description><content:encoded><![CDATA[【市场】80亿降压药白云山过评，39家药企激战]]></content:encoded><pubDate>Tue, 09 Mar 2021 16:26:55 +0800</pubDate></item><item><title>20个妇科中成药药店大卖！恩威、千金、步长……11个独家产品“霸屏”，这3个逆势增长</title><link>https://mp.weixin.qq.com/s/LjswfWTnB9rwkq_mmO64Xg</link><description></description><content:encoded><![CDATA[20个妇科中成药药店大卖！恩威、千金、步长……11个独家产品“霸屏”，这3个逆势增长]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:42:29 +0800</pubDate></item><item><title>【审评】10亿注射剂！齐鲁、海思科刚过评，苑东也来了</title><link>https://mp.weixin.qq.com/s/gS3MUzU5AS-mNALP__ZFpQ</link><description></description><content:encoded><![CDATA[【审评】10亿注射剂！齐鲁、海思科刚过评，苑东也来了]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:42:29 +0800</pubDate></item></channel></rss>